Agenix Limited was listed on the Australian Stock Exchange in October 1987. Today's two primary businesses consist of AGEN Biomedical (headquartered in Brisbane, Australia) and Agenix Bio-Pharma Shanghai, in The People's Republic of China.

For more information regarding the stock, board or investor relations, please select any of the links to the left.

27 Jul 2010
Notice of Annual General Meeting

01 Jul 2010
Agenix recoveries in China continue

08 Jun 2010
Update on path back to trading shares on ASX

04 Jun 2010
Half Yearly Report and Accounts